Drug Screening Market | Industry Size, Analysis, Future Scope, Growth, Trends, and Foreca


Posted June 24, 2019 by healthcaremarket

Drug Screening Market worth $13.89 billion by 2027

 
The report "Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2027", is expected to reach USD 13.89 billion by 2027 from USD 5.32 billion in 2017, at a CAGR of 10.2%. This high growth rate is attributed to factors such as growing drug and alcohol consumption; government funding in major markets, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals and new product and service launches.

Browse 204 market data Tables and 42 Figures spread through 203 Pages and in-depth TOC on "Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/drug-alcohol-screening-market-162987773.html

Breathalyzers are expected to dominate the drug screening products market in 2017.
Based on product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. In 2017, the breathalyzers segment is expected to dominate the market. Growing alcohol consumption and drunken driving cases, stringent government laws mandating drug and alcohol testing, and technological advancements in this market are some of the key factors driving the growth of the breathalyzers market.

Based on sample type, the oral fluid segment is projected to grow at the highest CAGR during the forecast period.
By sample type, drug screening market is segmented into urine, breath, oral fluid, hair, and other samples. Among these the oral fluid segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing preference for oral fluid samples because of the convenient collection method, no specific requirement for sample collection, and low risk of sample adulteration.

Visit: https://www.marketsandmarkets.com/PressReleases/drug-alcohol-screening.asp
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Country United States
Categories Health
Tags drug screening market
Last Updated June 24, 2019